Colin J Meyer

USPTO Granted Patents = 9 (Patent Applications = 5)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 204(Granted Patents)

Location History:

Frisco, TX (US) (2012 - 2017)
Southlake, TX (US) (2014 - 2024)

Company Filing History:

7 out of 61

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals Holdings, LLC

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11911395 - Methods of treating obesity using antioxidant inflammation modulators (2024-02-27),

2. 11446313 - Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof (2022-09-20),

3. 10953020 - Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof (2021-03-23),

4. 10105372 - Methods of treating obesity using antioxidant inflammation modulators (2018-10-23),

5. 9757359 - Synthetic triterpenoids and methods of use in the treatment of disease (2017-09-12),

6. 9155721 - Delayed release, oral dosage compositions that contain amorphous CDDO-Me (2015-10-13),

7. 8747901 - Delayed release, oral dosage compositions that contain amorphous CDDO-Me (2014-06-10),

8. 8455544 - Synthetic triterpenoids and methods of use in the treatment of disease (2013-06-04),

9. 8129429 - Synthetic triterpenoids and methods of use in the treatment of disease (2012-03-06),

Title: Colin J Meyer: Innovator in Obesity and Kidney Disease Treatments

Introduction

Colin J Meyer is a prominent inventor based in Southlake, TX (US), known for his significant contributions to medical treatments. With a total of 9 patents to his name, he has focused on innovative methods to address critical health issues such as obesity and Alport syndrome.

Latest Patents

Meyer’s latest patents include groundbreaking methods of treating obesity using antioxidant inflammation modulators. This invention relates to the administration of compounds like bardoxolone methyl to prevent and treat obesity. Additionally, he has developed methods for treating Alport syndrome using bardoxolone methyl or its analogs, aimed at improving kidney function in affected patients.

Career Highlights

Throughout his career, Colin J Meyer has worked with notable organizations, including Reata Pharmaceuticals, Inc. and Dartmouth College. His work has been instrumental in advancing medical research and developing effective treatment options for patients.

Collaborations

Meyer has collaborated with esteemed colleagues such as Michael B Sporn and Karen T Liby, contributing to the advancement of his research and innovations.

Conclusion

Colin J Meyer stands out as an influential inventor in the fields of obesity and kidney disease treatment. His innovative patents and collaborations reflect his commitment to improving patient health outcomes.

This text is generated by artificial intelligence and may not be accurate.